[Federal Register Volume 64, Number 191 (Monday, October 4, 1999)]
[Notices]
[Pages 53680-53681]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-25683]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention
[INFO-99-43]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506 (c) (2) (A) of 
the Paperwork reduction Act of 1995, the Center for Disease Control and 
Prevention is providing opportunity for public comment on proposed data 
collection projects. To request more information on the proposed 
projects or to obtain a copy of the data collection plans and 
instruments, call the CDC Reports Clearance Officer on (404) 639-7090.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) The accuracy of the agency's estimate of the burden of the

[[Page 53681]]

proposed collection of information; (c) Ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) Ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques for other 
forms of information technology. Send comments to Seleda Perryman, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.

Proposed Projects

    Multi-Center Cohort Study to Assess the Risk and Consequences of 
Hepatitis C Virus Transmission from Mother to Infant (0920-0344)--
Renewal--The National Center for Infectious Diseases (NCID)--The 
purpose of the proposed study is (1) To determine the incidence of 
vertical hepatitis C virus (HCV) transmission, (2) To assess risk 
factors for vertical HCV transmission, (3) To assess the clinical 
course of disease among infants with HCV infection, and (4) To assess 
diagnostic methods for detecting HCV infection in infants. HCV is a 
blood-borne pathogen and is the major etiologic agent of what was 
previously referred to as parenterally-transmitted non-A, non-B 
hepatitis. Diagnostic tests for HCV infection have recently been 
developed and HCV has been demonstrated to account for about 20% of all 
cases of viral hepatitis in the United States. Virtually all adults 
with acute HCV infection may become chronically infected and 50%-60% 
may develop chronic liver disease with persistently elevated liver 
enzymes. Of adults with chronic liver disease, 30%-60% may develop 
chronic active hepatitis and 5%-20% may develop cirrhosis within five 
years after illness onset. HCV is also a major contributing cause of 
hepatocellular carcinoma. An estimated 8,000-10,000 chronic liver 
disease deaths per year in the United States are attributable to HCV 
infection. There are no costs to respondents other than their time to 
participate.

----------------------------------------------------------------------------------------------------------------
                                                                                   Burden  hours
                    Form name                         No. of       No. responses        per        Total burden
                                                    respondents   per respondent    respondent         hours
----------------------------------------------------------------------------------------------------------------
Form A..........................................             300               1            0.25              75
Form B..........................................            1200               1            0.25             300
Form C..........................................             300               1            0.10              30
Form E..........................................             300               1            0.25              75
Form G..........................................             300               8            0.10             240
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............             720
----------------------------------------------------------------------------------------------------------------

    2. Chronic Fatigue Syndrome (CFS) Surveillance and Related Studies, 
Prevalence and Incidence of Fatiguing Illness in Sedgewick County, 
Kansas (0920-0401)--Renewal--The National Center for Infectious 
Diseases (NCID)--A Population-Based CFS Study was done previously in 
Kansas in 1997. Data from this cross-sectional, random-digit-dial 
survey of prolonged fatiguing illness in Wichita, Kansas will be added 
to the data previously obtained during the past 24-months from this 
population.
    The proposed study continues the Sedgwick County study using 
identical methodology and data collection instruments. Beginning with a 
random-digit-dial telephone survey to identify previously identified 
fatigued and non-fatigued individuals, followed by a detailed telephone 
interview to obtain additional data on participants' health status 
during the last 12-month period. Study objectives remain to refine 
estimates of CFS in Wichita, identify similarities and differences 
among fatigued and non-fatigued subjects and to describe the clinical 
course of fatiguing illness in this population.

----------------------------------------------------------------------------------------------------------------
                                                                      No. of      Average burden/
                   Respondents                        No. of        responses/      respondent     Total burden
                                                    respondents     respondent       (in hrs.)       (in hrs.)
----------------------------------------------------------------------------------------------------------------
Individuals screened............................           4,500               1           0.083             374
Individuals interviewed.........................           4,500               1           0.25            1,125
                                                 ---------------------------------------------------------------
    Total.......................................  ..............  ..............  ..............           1,499
----------------------------------------------------------------------------------------------------------------

Nancy Cheal,
Acting Associate Director for Policy, Planning, and Evaluation, Centers 
for Disease Control and Prevention (CDC).
[FR Doc. 99-25683 Filed 10-1-99; 8:45 am]
BILLING CODE 4163-18-P